245 related articles for article (PubMed ID: 29133669)
1. Severe
Salceanu SO; Levy S; Cunningham R; Frimpong-Ansah K
Indian J Ophthalmol; 2017 Nov; 65(11):1249-1251. PubMed ID: 29133669
[TBL] [Abstract][Full Text] [Related]
2. Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.
Damasceno NP; Horowitz SA; Damasceno EF
Ocul Immunol Inflamm; 2016; 24(1):118-9. PubMed ID: 24749654
[TBL] [Abstract][Full Text] [Related]
3. Gemella haemolysans keratitis and consecutive endophthalmitis.
Ritterband D; Shah M; Kresloff M; Intal M; Shabto U; Seedor J
Am J Ophthalmol; 2002 Feb; 133(2):268-9. PubMed ID: 11812434
[TBL] [Abstract][Full Text] [Related]
4. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
Patel SN; Storey PP; Pancholy M; Obeid A; Wibbelsman TD; Levin H; Hsu J; Garg SJ; Dunn JP; Vander JF
Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
[TBL] [Abstract][Full Text] [Related]
5. Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.
Souied EH; Dugel PU; Ferreira A; Hashmonay R; Lu J; Kelly SP
Ophthalmic Epidemiol; 2016; 23(2):71-9. PubMed ID: 26855278
[TBL] [Abstract][Full Text] [Related]
6. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
Rayess N; Rahimy E; Storey P; Shah CP; Wolfe JD; Chen E; DeCroos FC; Garg SJ; Hsu J
Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
[TBL] [Abstract][Full Text] [Related]
7. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C;
Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
[TBL] [Abstract][Full Text] [Related]
8. Comparative Study of Microbiological Profile and Management Outcomes of Acute Endophthalmitis after Microincision Vitrectomy Surgery versus Intravitreal Injections.
Kannan NB; Sen S; Mishra C; Lalitha P; Rameshkumar G; Rajan RP; Arumugam KK; Ramasamy K
Ocul Immunol Inflamm; 2021 Jul; 29(5):838-844. PubMed ID: 31900009
[No Abstract] [Full Text] [Related]
9. Abiotrophia defectiva bleb-associated endophthalmitis confirmed with 16s ribosomal RNA sequencing.
Hugo Lee MH; Lawlor M; Lee AJ
J Glaucoma; 2015 Jan; 24(1):87-8. PubMed ID: 23970342
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.
Mezad-Koursh D; Goldstein M; Heilwail G; Zayit-Soudry S; Loewenstein A; Barak A
Retina; 2010; 30(7):1051-7. PubMed ID: 20616683
[TBL] [Abstract][Full Text] [Related]
11. Gemella species-associated late-onset endophthalmitis after trabeculectomy with adjunctive mitomycin C.
Sawada A; Mochizuki K; Katada T; Kawakami H; Yamamoto T; Mikamo H; Watanabe K
J Glaucoma; 2009 Aug; 18(6):496-7. PubMed ID: 19680060
[TBL] [Abstract][Full Text] [Related]
12. Endophthalmitis following intravitreal injections.
Irigoyen C; Ziahosseini K; Morphis G; Stappler T; Heimann H
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):499-505. PubMed ID: 22048244
[TBL] [Abstract][Full Text] [Related]
13. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA
Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
[TBL] [Abstract][Full Text] [Related]
14. Post-intravitreal injection endophthalmitis secondary to Turicella otitidis: a case report.
Mammo DA; Watson D; Armbrust KR
BMC Ophthalmol; 2020 Apr; 20(1):142. PubMed ID: 32276621
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic bacteriuria and acute-onset endophthalmitis after cataract surgery.
Margo CE
Can J Ophthalmol; 2015 Aug; 50(4):e51-2. PubMed ID: 26257232
[No Abstract] [Full Text] [Related]
16. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
[TBL] [Abstract][Full Text] [Related]
17. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT).
Meredith TA; McCannel CA; Barr C; Doft BH; Peskin E; Maguire MG; Martin DF; Prenner JL;
Ophthalmology; 2015 Apr; 122(4):817-21. PubMed ID: 25600198
[TBL] [Abstract][Full Text] [Related]
18. Enterococcus casseliflavus endophthalmitis associated with a horse tail injury.
Khurana RN; Leder HA; Nguyen QD; Do DV
Arch Ophthalmol; 2009 Nov; 127(11):1551-2. PubMed ID: 19901232
[No Abstract] [Full Text] [Related]
19. Bilateral endophthalmitis following bilateral same-day anti-VEGF injections.
Sepetis AE; Clarke B; Gupta B
Acta Ophthalmol; 2021 Feb; 99(1):e131-e133. PubMed ID: 32533656
[No Abstract] [Full Text] [Related]
20. Vitreous hemorrhage as an early sign of acute bacterial endophthalmitis following intravitreal ranibizumab injection.
Weill Y; Brosh K; Levi-Vineberg T; Hanhart J
Int Ophthalmol; 2018 Apr; 38(2):799-802. PubMed ID: 28365853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
